Journey of an Employee to becoming an Employer: Mr. RC Juneja

1673

Having worked as a diligent employer in Lupin Limited, Mr. RC Juneja formed his own venture with a name Bestochem in Partnership with his two other brothers, in 1983. In 1994, he pulled back his proprietorship from Bestochem and in 1995 incepted his bootstrapped company Mankind Pharma, alongside his younger brother Mr. Rajeev Juneja with an initial investment of Rs. 50 lakhs and with a team of 25 Medical Representatives. Since then there has been no stopping!

Under the supervision of R C Juneja, Mankind flourished from a Rs. 3.49 crores organization in 1995 to an organization with a turnaround of over Rs. 1500 crores today. Mankind today is among the top five fastest growing pharmaceutical organizations of India with a representative base of more than 10,000 and heading towards a turnover of Rs 3,400 crore. They aim to aid each section of society and helping them lead a healthy and comfortable life, with the help of 2 basic objectives: formulating, developing & commercialising medicines and delivering affordable & accessible medication that satisfies urgent medical needs.

Their strong company portfolio, topographies and products ranging from pharma to mainstream OTC and FMCG brands — Unwanted72, PregaNews, Kustody, Adiction, Gas-O-Fast, and Manforce condoms, have given them the key advantages of incorporation that permit them to perform best in an inexorably focused market.

They aspire to aid the community in leading a healthy life through two parallel objectives: formulating, developing & commercialising medicines and delivering affordable & accessible medication that satisfies urgent medical needs. In 2010, Mankind propelled its first abroad market, SriLanka and they were diligently growing the skyline in Vietnam, Philippines, Myanmar, African market, CIS and other directed and semi-controlled markets by 2015.

Creating a differentiating USP in market

Mankind Pharma’s central goal is to give high quality drugs at reasonable costs for more beneficial lives, with the plan of action spreading over crosswise over three portions: generics, active pharmaceutical ingredients and OTC products.

With a ‘Bottom to top of the pyramid’ approach, Mankind Pharma has possessed the capacity to enter with reasonable and effectively accessible medications in India’s residential communities and towns, which had been dismissed otherwise. As indicated by IMS Health, a US-based firm that gathers restrictive industry information, Mankind Pharma was available in each town in India that had at least 1,000 tenants in 2009, which added to 58% of the organization’s income. They possess the biggest deals constrain in the segment for infiltrating niche and corner of the nation and deal with a low whittling down rate at a large portion of the business level.
Mr. RC Juneja is the driving force behind the success of Mankind Pharma. His insight into every aspect of marketing is giving Mankind a competitive edge in the market.